Medtronic plc Capital Reinvestment Ratio

Latest as of April 2026: 0.19x

Medtronic plc capital reinvestment ratio. Medtronic plc (MDTC34) has a Capital Reinvestment Ratio of 0.19x as of April 2026, meaning it reinvests 0% of its operating cash flow (R$2.57 Billion) in capital expenditures (R$488.00 Million). Check Medtronic plc (MDTC34) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.19x
Capex / Operating Cash Flow

Operating Cash Flow

R$2.57 Billion
BRL

Capital Expenditures

R$488.00 Million
BRL

Data as of

Apr 2026
Most recent filing

Capital Reinvestment Ratio of Medtronic plc (2019–2026)

Capital reinvestment ratio of Medtronic plc from 2019 to 2026. This chart tracks Medtronic plc's Capital Reinvestment Ratio across 8 annual periods. Also explore Medtronic plc equity growth rate to track the company's year-over-year net asset growth rate.

Medtronic plc Capital Reinvestment Ratio by Year (2019–2026)

Medtronic plc capital reinvestment ratio by year from 2019 to 2026. For the full cash flow conversion analysis, see cash flow conversion of Medtronic plc.

Year Reinvestment Ratio Operating CF (BRL) Capital Expenditures YoY Change
2026 0.26x R$7.33 Billion R$1.90 Billion ▼ -1.6%
2025 0.26x R$7.04 Billion R$1.86 Billion ▲ +12.9%
2024 0.23x R$6.79 Billion R$1.59 Billion ▼ -3.2%
2023 0.24x R$6.04 Billion R$1.46 Billion ▲ +29.7%
2022 0.19x R$7.35 Billion R$1.37 Billion ▼ -14.2%
2021 0.22x R$6.24 Billion R$1.35 Billion ▲ +29.5%
2020 0.17x R$7.23 Billion R$1.21 Billion ▲ +3.6%
2019 0.16x R$7.01 Billion R$1.13 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow